enbucrilate has been researched along with Seizures in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heuer, GG; Hurst, RW; Lang, SS; Madsen, PJ; Pisapia, JM; Storm, PB | 1 |
Chen, B; Chen, S; Chen, Z; Fang, Z; Li, Z; Ni, G; Ning, Y; Qin, J; Wu, C; Zhou, J; Zhou, L | 1 |
Bascoulergues, Y; Deruty, R; Garcia, C; Lapras, C; Patet, JD; Pialat, J; Pierluca, P | 1 |
1 review(s) available for enbucrilate and Seizures
Article | Year |
---|---|
An institutional series and literature review of pial arteriovenous fistulas in the pediatric population: clinical article.
Topics: Arteriovenous Fistula; Cerebral Hemorrhage; Embolization, Therapeutic; Enbucrilate; Female; Humans; Infant; Intracranial Arteriovenous Malformations; Male; Megalencephaly; Prognosis; Retrospective Studies; Risk Factors; Seizures; Treatment Outcome | 2013 |
2 other study(ies) available for enbucrilate and Seizures
Article | Year |
---|---|
Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Disease Models, Animal; Drug Resistance; Enbucrilate; Epilepsy, Temporal Lobe; Female; Hippocampus; Lithium; Nanoparticles; Phenytoin; Pilocarpine; Poloxalene; Rats, Sprague-Dawley; Reproducibility of Results; Seizures; Tissue Distribution | 2016 |
[Peroperative embolization of cerebral arteriovenous malformations with butylcyanoacrylate (18 cases)].
Topics: Cerebral Angiography; Embolization, Therapeutic; Enbucrilate; Female; Humans; Intracranial Arteriovenous Malformations; Intraoperative Period; Male; Postoperative Complications; Seizures; Subtraction Technique; Tomography, X-Ray Computed | 1985 |